PortfoliosLab logoPortfoliosLab logo
FBTU.L vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FBTU.L vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FBTU.L achieves a 8.73% return, which is significantly lower than IHE's 9.33% return.


FBTU.L

1D
4.34%
1M
9.71%
YTD
8.73%
6M
6.95%
1Y
38.25%
3Y*
13.28%
5Y*
6.94%
10Y*

IHE

1D
2.69%
1M
3.48%
YTD
9.33%
6M
12.42%
1Y
43.59%
3Y*
18.33%
5Y*
10.57%
10Y*
7.97%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FBTU.L vs. IHE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
FBTU.L
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating
8.73%25.95%4.74%3.91%-5.96%-3.77%3.88%
IHE
iShares U.S. Pharmaceuticals ETF
9.33%31.69%8.13%1.06%-4.87%13.07%15.06%

Correlation

The correlation between FBTU.L and IHE is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.51

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (5Y)
Calculated over the trailing 5-year period

0.42

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2020

0.41

The correlation between FBTU.L and IHE has been stable across timeframes, ranging from 0.41 to 0.51 - a consistent structural relationship.

FBTU.L vs. IHE - Sectors Allocation Comparison


Sectors
FBTU.L
IHE

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

FBTU.L
100.0%
IHE
100.0%

Basic Materials

FBTU.L

-

IHE

-

Communication Services

FBTU.L

-

IHE

-

Consumer Cyclical

FBTU.L

-

IHE

-

Consumer Defensive

FBTU.L

-

IHE

-

Energy

FBTU.L

-

IHE

-

Financial Services

FBTU.L

-

IHE

-

Industrials

FBTU.L

-

IHE

-

Real Estate

FBTU.L

-

IHE

-

Technology

FBTU.L

-

IHE

-

Utilities

FBTU.L

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FBTU.L vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBTU.L
FBTU.L Risk / Return Rank: 5252
Overall Rank
FBTU.L Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
FBTU.L Sortino Ratio Rank: 5757
Sortino Ratio Rank
FBTU.L Omega Ratio Rank: 4949
Omega Ratio Rank
FBTU.L Calmar Ratio Rank: 5555
Calmar Ratio Rank
FBTU.L Martin Ratio Rank: 4545
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 8181
Overall Rank
IHE Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 8383
Sortino Ratio Rank
IHE Omega Ratio Rank: 7373
Omega Ratio Rank
IHE Calmar Ratio Rank: 8888
Calmar Ratio Rank
IHE Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBTU.L vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FBTU.LIHEDifference
Sharpe ratioReturn per unit of total volatility

-0.75

Sortino ratioReturn per unit of downside risk

-1.01

Omega ratioGain probability vs. loss probability

1.30

1.43

-0.12

Calmar ratioReturn relative to maximum drawdown

2.66

5.17

-2.51

Martin ratioReturn relative to average drawdown

7.17

15.58

-8.40

FBTU.L vs. IHE - Sharpe Ratio Comparison

The current FBTU.L Sharpe Ratio is 1.79, which is comparable to the IHE Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of FBTU.L and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


FBTU.LIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.79

2.54

-0.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.33

0.65

-0.32

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

0.27

0.51

-0.24

Drawdowns

FBTU.L vs. IHE - Drawdown Comparison

The maximum FBTU.L drawdown since its inception was -33.73%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FBTU.L and IHE.


Loading charts...

Drawdown Indicators


FBTU.LIHEDifference

Max Drawdown

Largest peak-to-trough decline

-33.73%

-38.20%

+4.47%

Max Drawdown (1Y)

Largest decline over 1 year

-14.30%

-8.47%

-5.83%

Max Drawdown (3Y)

Largest decline over 3 years

-22.47%

-15.92%

-6.55%

Max Drawdown (5Y)

Largest decline over 5 years

-29.97%

-16.03%

-13.94%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

Current Drawdown

Current decline from peak

0.00%

-0.18%

+0.18%

Average Drawdown

Average peak-to-trough decline

-13.11%

-7.92%

-5.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.32%

2.81%

+2.51%

Volatility

FBTU.L vs. IHE - Volatility Comparison

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) has a higher volatility of 7.25% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 6.04%. This indicates that FBTU.L's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FBTU.LIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.25%

6.04%

+1.21%

Volatility (6M)

Calculated over the trailing 6-month period

16.34%

12.70%

+3.64%

Volatility (1Y)

Calculated over the trailing 1-year period

21.31%

17.26%

+4.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.91%

16.28%

+4.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.38%

18.07%

+3.31%

FBTU.L vs. IHE - Expense Ratio Comparison

FBTU.L has a 0.60% expense ratio, which is higher than IHE's 0.42% expense ratio.


Dividends

FBTU.L vs. IHE - Dividend Comparison

FBTU.L has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.61%.


PositionTTM20252024202320222021202020192018201720162015
FBTU.L
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF
1.61%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


FBTU.L and IHE have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, IHE is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.

IHE is cheaper with a 0.42% expense ratio, compared with 0.60% for FBTU.L.

They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FBTU.L and 0.42% for IHE.

Portfolio Optimizer

Find the right allocation for FBTU.L and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer